Aptevo Therapeutics logo

Aptevo Therapeutics share price today

(APVO)

Aptevo Therapeutics share price is $4.57 & ₹391.83 as on 3 Jan 2025, 2.30 'hrs' IST

$4.57

0.26

(6.03%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Aptevo Therapeutics share price in Dollar and Rupees. Guide to invest in Aptevo Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Aptevo Therapeutics. Get details on the Indian mutual funds that are investing in Aptevo Therapeutics. Get Analyst recommendations and forecasts along with all the Aptevo Therapeutics's financials.

Aptevo Therapeutics share price movements

  • Today's Low: $4.37
    Today's High: $4.66

    Day's Volatility :6.22%

  • 52 Weeks Low: $3.65
    52 Weeks High: $399.60

    52 Weeks Volatility :99.09%

Aptevo Therapeutics Returns

PeriodAptevo Therapeutics IncIndex (Russel 2000)
3 Months
-31.11%
0.0%
6 Months
-60.09%
0.0%
1 Year
-98.5%
0.0%
3 Years
-99.97%
-21.2%

Aptevo Therapeutics Key Statistics

in dollars & INR

Previous Close
$4.31
Open
$4.42
Today's High
$4.66
Today's Low
$4.37
Market Capitalization
$6.3M
Today's Volume
$116.4K
52 Week High
$399.6
52 Week Low
$3.65
Revenue TTM
$0.0
EBITDA
$-24.2M
Earnings Per Share (EPS)
$-415.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-250.96%

How to invest in Aptevo Therapeutics from India?

It is very easy for Indian residents to invest directly in Aptevo Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aptevo Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aptevo Therapeutics or APVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aptevo Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aptevo Therapeutics shares which would translate to 0.188 fractional shares of Aptevo Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aptevo Therapeutics, in just a few clicks!

Returns in Aptevo Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aptevo Therapeutics investment value today

Current value as on today

₹4,564

Returns

₹95,436

(-95.44%)

Returns from Aptevo Therapeutics Stock

₹98,411 (-98.41%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Aptevo Therapeutics

4.55%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Investment in Aptevo Therapeutics from India has grown in the last 30 days as on Jan 3, 2025. 4.55% more purchase transactions for Aptevo Therapeutics in the last 30 days versus the previous period.

52%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Aptevo Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 52% more investors are searching Aptevo Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Aptevo Therapeutics

  • Hudson Bay Capital Management LP

    5.05%

  • Citadel Advisors Llc

    0.60%

  • Geode Capital Management, LLC

    0.24%

  • Virtu Financial LLC

    0.23%

  • Renaissance Technologies Corp

    0.20%

  • HRT FINANCIAL LLC

    0.15%

Analyst Recommendation on Aptevo Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Aptevo Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aptevo Therapeutics

What analysts predicted

Upside of 359.52%

Current:

$4.57

Target:

$21.00

Insights on Aptevo Therapeutics

  • Price Movement

    In the last 7 days, APVO stock has moved down by -15.7%
  • APVO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 119.2%
  • APVO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 138.8%

Aptevo Therapeutics Technicals Summary

Sell

Neutral

Buy

Aptevo Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Aptevo Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aptevo Therapeutics Inc
-50.43%
-60.09%
-98.5%
-99.97%
-99.97%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aptevo Therapeutics Inc
NA
NA
0.0
-85.96
-2.51
-0.73
NA
0.26
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aptevo Therapeutics Inc
Buy
$6.3M
-99.97%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Aptevo Therapeutics

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology.
Organization
Aptevo Therapeutics
Employees
40
CEO
Mr. Marvin L. White
Industry
Health Technology

Management People of Aptevo Therapeutics

NameTitle
Mr. Marvin L. White
President, CEO & Director
Mr. Jeffrey G. Lamothe CA
Executive VP & COO
Ms. SoYoung Kwon J.D., LL.M.
Senior VP, General Counsel, Business Development & Corporate Affairs
Ms. Daphne L. Taylor CPA
Senior VP & CFO
Dr. Dirk Huebner M.D.
Chief Medical Officer

Important FAQs about investing in Aptevo Therapeutics from India :

What is Aptevo Therapeutics share price today?

Aptevo Therapeutics share price today stands at $4.57, Open: $4.42 ; Previous Close: $4.31 ; High: $4.66 ; Low: $4.37 ; 52 Week High: $399.60 ; 52 Week Low: $3.65. The stock opens at $4.42, after a previous close of $4.31. The stock reached a daily high of $4.66 and a low of $4.37, with a 52-week high of $399.60 and a 52-week low of $3.65.

Can Indians buy Aptevo Therapeutics shares?

Yes, Indians can invest in the Aptevo Therapeutics (APVO) from India.

With INDmoney, you can buy Aptevo Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aptevo Therapeutics at zero transaction cost.

How can I buy Aptevo Therapeutics shares from India?

It is very easy to buy Aptevo Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aptevo Therapeutics be purchased?

Yes, you can buy fractional shares of Aptevo Therapeutics with INDmoney app.

What are the documents required to start investing in Aptevo Therapeutics stocks?

To start investing in Aptevo Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aptevo Therapeutics

Today’s highest price of Aptevo Therapeutics (APVO) is $4.66.

Today’s lowest price of Aptevo Therapeutics (APVO) is $4.37.

What is today's market capitalisation of Aptevo Therapeutics

Today's market capitalisation of Aptevo Therapeutics APVO is 6.3M

What is the 52 Week High and Low Range of Aptevo Therapeutics

  • 52 Week High

    $399.60

  • 52 Week Low

    $3.65

What are the historical returns of Aptevo Therapeutics?

  • 1 Month Returns

    -50.43%

  • 3 Months Returns

    -60.09%

  • 1 Year Returns

    -98.5%

  • 5 Years Returns

    -99.97%

Who is the Chief Executive Officer (CEO) of Aptevo Therapeutics

Mr. Marvin L. White is the current Chief Executive Officer (CEO) of Aptevo Therapeutics.